In-House Prescription Drug Program
As the administrator for dozens of hospital health plans, SIHO is aware that not all hospitals are taking advantage of the tremendous savings available
to them with their health plan prescription drug program under the 340B or Non-Profit Institutions Act (NPIA). For most hospitals, these savings will range
from 12% to 40% over their current prescription drug program.
SIHO can help a hospital understand and evaluate these two programs and determine whether either is feasible for their health plan population. This evaluation will include eligibility, logistics, financial modeling, legal, and implementation. SIHO also has access to industry leading experts in this field should additional resources be necessary.
Depending on which program is implemented, SIHO can also assist the hospital in extending the program more broadly community-wide to increase their value position.